EU helps Georgian biotech company reduce the use of antibiotics in meat production
The EU and FAO have awarded a matching grant of US$150,000 to Biochimpharm, a Georgian biotech company that gained worldwide recognition producing bacteriophages. The funding will support ‘PowerPhage’ production, a bacteriophage, natural antimicrobial veterinary solution, which reduces the use of antibiotics in meat production, with a focus on poultry farms.
The EU and FAO grant is expected to create new jobs and help the company grasp its tremendous export potential on the EU market. It is a part of a total US$1,000,000 investment, raised by the company, aimed to allow a 300% increase in PowerPhage production.
The EU is supporting agriculture and rural development in Georgia through its ENPARD programme. Implemented since 2013 with a total budget of €234.5 million, the main goal of ENPARD is to provide economic opportunities in rural areas and reduce poverty in Georgia.
Find out more
MOST READ
[popular_posts columns_xl=”4″ columns_l=”4″ columns_m=”3″]
